Literature DB >> 3029097

Structure determination of five sulfated oligosaccharides derived from tracheobronchial mucus glycoproteins.

T P Mawhinney, E Adelstein, D A Morris, A M Mawhinney, G J Barbero.   

Abstract

The structure of five sulfated oligosaccharide units of highly anionic tracheobronchial mucous glycoproteins, isolated from a cystic fibrosis patient's sputum, were established. Reduced oligosaccharides (84%) were released under alkaline borohydride conditions, and the acidic oligosaccharides (63%) were isolated by Dowex 1-X2 chromatography. Following the removal of acidic oligosaccharides possessing N-acetylneuraminic acid and L-fucose by lectin affinity chromatography a heterogeneous mixture of sulfated oligosaccharides was obtained. From this fraction, five short chain monosulfated oligosaccharides (S-I to S-V) were purified by sequential separation by SynChroprep AX300 anion exchange high pressure liquid chromatography, gel filtration on Bio-Gel P-2, and high voltage paper electrophoresis. Based on the results of carbohydrate composition, sequential exoglycosidase degradation, permethylation analysis, lectin affinity chromatography, and periodate oxidation, the following structures (where GalNAcol is N-acetylgalactosaminitol) were proposed for these oligosaccharides. (formula; see text)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029097

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.

Authors:  J Mendicino; S Sangadala
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  Carbohydrate analysis of glycoproteins. A review.

Authors:  K B Lee; D Loganathan; Z M Merchant; R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1990-01       Impact factor: 2.926

3.  Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits.

Authors:  G Dekan; C Gabel; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA.

Authors:  J H Hannah; F D Menozzi; G Renauld; C Locht; M J Brennan
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 5.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

6.  Structure of two sulphated oligosaccharides from respiratory mucins of a patient suffering from cystic fibrosis. A fast-atom-bombardment m.s. and 1H-n.m.r. spectroscopic study.

Authors:  G Lamblin; H Rahmoune; J M Wieruszeski; M Lhermitte; G Strecker; P Roussel
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

7.  Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells.

Authors:  Miyako Nakano; Rohit Saldanha; Anja Göbel; Maria Kavallaris; Nicolle H Packer
Journal:  Mol Cell Proteomics       Date:  2011-08-22       Impact factor: 5.911

8.  Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl-Lewis x epitope.

Authors:  Baoyun Xia; Goverdhan P Sachdev; Richard D Cummings
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

9.  Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

Authors:  R Ramphal; N Houdret; L Koo; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

10.  Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis.

Authors:  F D Menozzi; R Mutombo; G Renauld; C Gantiez; J H Hannah; E Leininger; M J Brennan; C Locht
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.